104 related articles for article (PubMed ID: 10716061)
1. Urinary excretion of phenobarbital and its metabolite p-hydroxyphenobarbital in convulsing and non-convulsing patients.
Brzakovic B; Pokrajac M; Dzoljic E; Levic Z; Varagic VM
Eur J Drug Metab Pharmacokinet; 1999; 24(3):233-6. PubMed ID: 10716061
[TBL] [Abstract][Full Text] [Related]
2. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
Whyte MP; Dekaban AS
Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.
Kokwaro GO; Ogutu BR; Muchohi SN; Otieno GO; Newton CR
Br J Clin Pharmacol; 2003 Oct; 56(4):453-7. PubMed ID: 12968992
[TBL] [Abstract][Full Text] [Related]
5. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience.
Hocker S; Clark S; Britton J
Epilepsia; 2018 Oct; 59 Suppl 2():193-197. PubMed ID: 30159873
[TBL] [Abstract][Full Text] [Related]
6. Very high dose phenobarbital for refractory status epilepticus.
Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of phenobarbitone and its metabolites in chronically treated patients.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Eur J Clin Pharmacol; 1994; 46(5):473-5. PubMed ID: 7957546
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of intravenous phenobarbital treatment for status epilepticus].
Muramoto E; Mizobuchi M; Sumi Y; Sako K; Nihira A; Takeuchi A; Nakamura H
Brain Nerve; 2013 Aug; 65(8):983-7. PubMed ID: 23917501
[TBL] [Abstract][Full Text] [Related]
9. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
[TBL] [Abstract][Full Text] [Related]
11. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
Bankstahl JP; Löscher W
Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic analysis of phenobarbital and phenobarbital metabolites in human urine.
Paibir SG; Soine WH
J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):111-7. PubMed ID: 9140764
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
[TBL] [Abstract][Full Text] [Related]
14. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.
Treiman DM; Meyers PD; Walton NY; Collins JF; Colling C; Rowan AJ; Handforth A; Faught E; Calabrese VP; Uthman BM; Ramsay RE; Mamdani MB
N Engl J Med; 1998 Sep; 339(12):792-8. PubMed ID: 9738086
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China.
Su Y; Liu G; Tian F; Ren G; Jiang M; Chun B; Zhang Y; Zhang Y; Ye H; Gao D; Chen W
CNS Drugs; 2016 Dec; 30(12):1201-1207. PubMed ID: 27878767
[TBL] [Abstract][Full Text] [Related]
16. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus.
Treiman DM; Walker MC
Epilepsy Res; 2006 Jan; 68 Suppl 1():S77-82. PubMed ID: 16384688
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
[TBL] [Abstract][Full Text] [Related]
18. Sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the quantification of phenobarbital and its p-hydroxyphenobarbital metabolite in rat urine.
Kadi A; Hefnawy M; Julkhuf S; Abounassif M; Mostafa G; Kassem MG; Attia S; Al-Ghamdi A
Analyst; 2011 Jul; 136(13):2858-65. PubMed ID: 21607283
[TBL] [Abstract][Full Text] [Related]
19. Effects of urine pH modification on pharmacokinetics of phenobarbital in healthy dogs.
Fukunaga K; Saito M; Muto M; Mishima K; Fujiwara M; Orito K
J Vet Pharmacol Ther; 2008 Oct; 31(5):431-6. PubMed ID: 19000262
[TBL] [Abstract][Full Text] [Related]
20. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
